Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
882.85 DKK | +0.86% | -2.52% | +26.33% |
09-10 | Health Care Up on Defensive Bias -- Health Care Roundup | DJ |
09-10 | Weight-loss market to see 16 new drugs by 2029, report estimates | RE |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Pharmaceutical Products | ||||||||||
Diabetes and Obesity Care | 103B | 108B | 122B | 156B | 215B | |||||
Total Assets | 86.7B | - | - | - | - | |||||
CAPEX | -9.64B | - | - | - | - | |||||
D&A | 3.92B | 4.62B | 4.9B | 5.7B | 8.2B | |||||
Operating Income | 42.64B | 43.74B | 49.54B | 67.4B | 99.62B | |||||
Rare Disease | 19.18B | 18.93B | 19.2B | 20.54B | 17.16B | |||||
Total Assets | 16.51B | - | - | - | - | |||||
CAPEX | -1.52B | - | - | - | - | |||||
D&A | 1.74B | 1.13B | 1.13B | 1.66B | 1.22B | |||||
Operating Income | 9.85B | 10.38B | 9.11B | 7.41B | 2.95B | |||||
Total Assets | - | - | - | - | - | |||||
Total Assets | 22.4B | - | - | - | - |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
The US | 57.49B | 57.82B | 63.01B | 84.66B | 128B | |||||
Total Assets | 39.46B | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
EMEA | - | 34.3B | 37.71B | 44.24B | 50.87B | |||||
Rest of World | - | 17.45B | 19.81B | 25.4B | 28.08B | |||||
Region China | 12.84B | 14.08B | 16.02B | 16.21B | 16.69B | |||||
Total Assets | 6.82B | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
North America (Excl. US) | 2.97B | 3.29B | 4.25B | 6.45B | 9.1B | |||||
Total Assets | 611M | - | - | - | - | |||||
Africa, Asia, Middle East and Oceania (AAMEO) | 14.09B | - | - | - | - | |||||
Total Assets | 6.73B | - | - | - | - | |||||
Latin America | 4.92B | - | - | - | - | |||||
Total Assets | 3.44B | - | - | - | - | |||||
Pacific | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Japan & Korea | 6.45B | - | - | - | - | |||||
Total Assets | 1.54B | - | - | - | - | |||||
North America | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Europe | 23.26B | - | - | - | - | |||||
Total Assets | 67.01B | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
International Operations | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - |
- Stock Market
- Equities
- NOVO B Stock
- Financials Novo Nordisk A/S
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition